These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31173193)

  • 1. Key genes associated with pancreatic cancer and their association with outcomes: A bioinformatics analysis.
    Wu J; Li Z; Zeng K; Wu K; Xu D; Zhou J; Xu L
    Mol Med Rep; 2019 Aug; 20(2):1343-1352. PubMed ID: 31173193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
    Zhou J; Hui X; Mao Y; Fan L
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of differentially expressed genes in pancreatic ductal adenocarcinoma and normal pancreatic tissues based on microarray datasets.
    Liu L; Wang S; Cen C; Peng S; Chen Y; Li X; Diao N; Li Q; Ma L; Han P
    Mol Med Rep; 2019 Aug; 20(2):1901-1914. PubMed ID: 31257501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
    Shang M; Zhang L; Chen X; Zheng S
    Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of hub genes and analysis of prognostic values in pancreatic ductal adenocarcinoma by integrated bioinformatics methods.
    Lu Y; Li C; Chen H; Zhong W
    Mol Biol Rep; 2018 Dec; 45(6):1799-1807. PubMed ID: 30173393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of molecular pathways in pancreatic ductal adenocarcinomas with a bioinformatics approach.
    Wang Y; Li Y
    Asian Pac J Cancer Prev; 2015; 16(6):2561-7. PubMed ID: 25824797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of key regulators of pancreatic ductal adenocarcinoma using bioinformatics analysis of microarray data.
    Li N; Zhao X; You S
    Medicine (Baltimore); 2019 Jan; 98(2):e14074. PubMed ID: 30633213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysis.
    Chen Q; Yu D; Zhao Y; Qiu J; Xie Y; Tao M
    J Cell Biochem; 2019 Dec; 120(12):19496-19508. PubMed ID: 31297881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysis.
    Islam S; Kitagawa T; Baron B; Abiko Y; Chiba I; Kuramitsu Y
    Sci Rep; 2021 May; 11(1):10563. PubMed ID: 34007003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated bioinformatics analysis of potential biomarkers for pancreatic cancer.
    Shi H; Xu H; Chai C; Qin Z; Zhou W
    J Clin Lab Anal; 2022 May; 36(5):e24381. PubMed ID: 35403252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Key Genes in Gastric Cancer by Bioinformatics Analysis.
    Chong X; Peng R; Sun Y; Zhang L; Zhang Z
    Biomed Res Int; 2020; 2020():7658230. PubMed ID: 33015179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma.
    Xiao Y; Zhang B; Cloyd JM; Xu G; Du S; Mao Y; Pawlik TM
    Surg Oncol; 2022 Sep; 44():101849. PubMed ID: 36116415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatic Analysis Suggests That Three Hub Genes May Be a Vital Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma.
    Chang X; Yang MF; Fan W; Wang LS; Yao J; Li ZS; Li DF
    J Comput Biol; 2020 Nov; 27(11):1595-1609. PubMed ID: 32216644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative bioinformatical analysis of pancreatic head cancer and pancreatic body/tail cancer.
    Yin L; Xiao L; Gao Y; Wang G; Gao H; Peng Y; Zhu X; Wei J; Miao Y; Jiang K; Lu Z
    Med Oncol; 2020 Apr; 37(5):46. PubMed ID: 32277286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible Molecular Markers for the Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Shen Q; Yu M; Jia JK; Li WX; Tian YW; Xue HZ
    Med Sci Monit; 2018 Apr; 24():2368-2376. PubMed ID: 29671412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a prognostic prediction system for pancreatic ductal adenocarcinoma to investigate the key prognostic genes.
    Zheng B; Peng J; Mollayup A; Bakri A; Guo L; Zheng J; Xu H
    Mol Med Rep; 2018 Jan; 17(1):216-224. PubMed ID: 29115420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.